検索結果 - David Nathanson

結果の絞り込み
  1. 1
    Insights into the mechanisms of lymph node metastasis

    Insights into the mechanisms of lymph node metastasis 著者: David Nathanson

    出版事項 2003
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Economic burden associated with breast cancer recurrence

    Economic burden associated with breast cancer recurrence 著者: Lois Lamerato, Suzanne Havstad, Sanjay Gandhi, David Jones, David Nathanson

    出版事項 2006
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes

    Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes 著者: David Nathanson, S., Leonard-Murali, Shravan, Burmeister, Charlotte, Susick, Laura, Baker, Patricia

    出版事項 2020
    全文の入手 全文の入手 全文の入手
    テキスト
    お気に入りに追加
    保存先:
  4. 4
    Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke

    Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke 著者: Vladimer Darsalia, Martin Larsson, David Nathanson, Thomas Klein, Thomas Nyström, Cesare Patrone

    出版事項 2015
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  5. 5
    Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality

    Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality 著者: Jan W. Eriksson, Johan Bodegård, David Nathanson, Marcus Thuresson, Thomas Nyström, Anna Norhammar

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

    Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 200... 著者: Anna Norhammar, Johan Bodegård, Thomas Nyström, Marcus Thuresson, Jan W. Eriksson, David Nathanson

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia

    Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and se... 著者: Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

    Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type... 著者: Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study

    Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study... 著者: Anna Norhammar, Johan Bodegård, Thomas Nyström, Marcus Thuresson, David Nathanson, Jan W. Eriksson

    出版事項 2019
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety

    Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety 著者: David Nathanson, Bengt Ullman, Ulrika Löfström, Anders Hedman, Mats Frick, Åke Sjöholm, Thomas Nyström

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

    Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive cont... 著者: David Nathanson, Ann‐Marie Svensson, Mervete Miftaraj, Stefan Franzén, Jan Bolinder, Katarina Eeg‐Olofsson

    出版事項 2021
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study

    Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study 著者: Henrik Falhammar, Jonatan D. Lindh, Jan Calissendorff, Shermineh Farmand, Jakob Skov, David Nathanson, Buster Mannheimer

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study

    History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks i... 著者: Viveca Ritsinger, Johan Bodegård, Robin Kristófi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan W. Eriksson, Anna Norhammar

    出版事項 2023
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

    Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study 著者: Robin Kristófi, Johan Bodegård, Anna Norhammar, Marcus Thuresson, David Nathanson, Thomas Nyström, Kåre I. Birkeland, Jan W. Eriksson

    出版事項 2021
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization

    Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization 著者: Vladimer Darsalia, Sansan Hua, Martin Larsson, Carina Mallard, David Nathanson, Thomas Nyström, Åke Sjöholm, Maria E. Johansson, Cesare Patrone

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes

    Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes 著者: Charles D. Callery, Alistair J. Cochran, Denise J. Roe, William V. Rees, S. David Nathanson, Jacqueline Benedetti, Robert M. Elashoff, Donald L. Morton

    出版事項 1982
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Comparison of Mammographically Guided Breast Biopsy Techniques

    Comparison of Mammographically Guided Breast Biopsy Techniques 著者: Vic Velanovich, Frank R. Lewis, David Nathanson, Vernon F. Strand, Gary B. Talpos, Srinivas Bhandarkar, Robert Elkus, Wanda Szymanski, John J. Ferrara

    出版事項 1999
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis

    An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis 著者: Gabi Tarcic, Shlomit Boguslavsky, Jean Wakim, Tai Kiuchi, A.H. Liu, Felicia Reinitz, David Nathanson, Takamune Takahashi, Paul S. Mischel, Tony Ng, Yosef Yarden

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin

    Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin 著者: Grażyna Lietzau, William Davidsson, Claes‐Göran Östenson, Fausto Chiazza, David Nathanson, Hiranya Pintana, Josefin Skogsberg, Thomas Klein, Thomas Nyström, Vladimer Darsalia, Cesare Patrone

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Mechanisms of breast cancer metastasis

    Mechanisms of breast cancer metastasis 著者: David Nathanson, Michael Detmar, Timothy P. Padera, Lucy Yates, Danny R. Welch, Thomas C. Beadnell, Adam D. Scheid, Emma D. Wrenn, Kevin J. Cheung

    出版事項 2021
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:

検索ツール: